AHCC (Active Hexose Correlated Compound) and immune markers

What 3 graded rows on ahcc (active hexose correlated compound) agree on for immune markers, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the AHCC (Active Hexose Correlated Compound) page, with its PubMed record.

Your question

Supplement
AHCC (Active Hexose Correlated Compound) Choose another

AHCC (Active Hexose Correlated Compound) and immune markers

3 rows · 95 people

Mostly an improvement: 2 of 3 rows, and most of the people. 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade D× 3
Rows
3
Trials
3
People
95

Where they differ

From the rows
How longWho was studiedWhen published

The best-graded row, grade D, is a randomized trial of 40 people (2019) and found no difference.

The 2 rows that found an improvement ran longer (4 weeks) than the row that found no difference (12 days).

Only the row that found no difference names men in its population.

The row that found no difference is newer (2019) than the 2 rows that found an improvement (2008 to 2015).

The rows

2 improved · 1 no difference
  1. Grade DImmune markers through early winter · Improved

    RCT · n 34 · 2015 · Thirty-four healthy subjects in Japan

    1.0 g a day · 4 weeks

    NK cell activity rose in both groups; NK cell numbers held steady on AHCC but fell on placebo, and an immune vigor score was maintained.

    Row on the AHCC (Active Hexose Correlated Compound) page · PubMed 25376719 (opens PubMed)

  2. Grade DDendritic cells in healthy volunteers · Improved

    RCT · n 21 · 2008 · Twenty-one healthy volunteers

    3.0 g a day · 4 weeks

    Total dendritic cells and the mixed-leukocyte reaction rose vs controls; NK cell activity, T-cell response and cytokines did not differ.

    Row on the AHCC (Active Hexose Correlated Compound) page · PubMed 18791928 (opens PubMed)

  3. Grade DImmune cells during an antibiotic course · No difference

    RCT · n 40 · 2019 · 40 healthy men, 10 per arm (placebo, probiotic BB536, AHCC, or both), given azithromycin from day 7

    Dose not stated in the abstract · 12 days

    T-cell cytokines did not differ between groups; only the AHCC plus BB536 combination shifted dendritic cells toward myeloid types vs baseline (80% vs 61%, p = 0.006).

    Row on the AHCC (Active Hexose Correlated Compound) page · PubMed 31618905 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.